<header id=056357>
Published Date: 2021-08-12 13:06:30 EDT
Subject: PRO/ALL> New in IJID (07): July 2021
Archive Number: 20210812.8580841
</header>
<body id=056357>
NEW IN INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (07): JULY 2021
*******************************************************************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org

Date: July 2021
Source: IJID [edited]
https://www.ijidonline.com/


Editorial
---------
Mandatory immunization against SARS-CoV-2 of athletes, companions and supporters for the Tokyo Olympics.
Petersen E, Schlagenhauf P, Lee SS, et al.
Int J Infect Dis. 2021;108:156-8. doi: 10.1016/j.ijid.2021.06.001.

Coronavirus (COVID-19) collection
---------------------------------
Reviews
-------
Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: a systematic meta-analysis of available data as of November 20, 2020.
Hayer J, Kasapic D, Zemmrich C.
Int J Infect Dis. 2021;108:592-602. doi: 10.1016/j.ijid.2021.05.029.

Association of lung ultrasound score with mortality and severity of COVID-19: a meta-analysis and trial sequential analysis.
Song G, Qiao W, Wang X, et al.
Int J Infect Dis. 2021;108:603-609. doi: 10.1016/j.ijid.2021.06.026.

Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: a systematic review and meta-analysis of adjusted effect estimates.
Martha JW, Pranata R, Lim MA, et al.
Int J Infect Dis. 2021;108:6-12. doi: 10.1016/j.ijid.2021.05.016.

Clinical
--------
Association of hypothermia with increased mortality rate in SARS-CoV-2 infection.
Fatteh N, Sutherland GE, Santos RG, et al.
Int J Infect Dis. 2021;108:167-170. doi: 10.1016/j.ijid.2021.05.031.

Inverse association between hypertension treatment and COVID-19 prevalence in Japan.
Kinoshita M, Sato K, Vellingiri B, et al.
Int J Infect Dis. 2021;108:517-21. doi: 10.1016/j.ijid.2021.05.071.

Association between risk of venous thromboembolism and mortality in patients with COVID-19.
Chen S, Zheng T, Wang S, et al.
Int J Infect Dis. 2021;108:543-549. doi: 10.1016/j.ijid.2021.06.005.

Multisystem inflammatory syndrome in adults: A rare sequela of SARS-CoV-2 infection.
Ahmad F, Ahmed A, Rajendraprasad SS, et al.
Int J Infect Dis. 2021;108:209-11. doi: 10.1016/j.ijid.2021.05.050.

Usefulness of the COVID-GRAM and CURB-65 scores for predicting severity in patients with COVID-19.
Arminanzas C, Arnaiz de Las Revillas F, Gutierrez Cuadra M, et al.
Int J Infect Dis. 2021;108:282-288. doi: 10.1016/j.ijid.2021.05.048.

Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: insights from the Cardio-COVID-Italy multicenter study.
Pagnesi M, Inciardi RM, Lombardi CM, et al.
Int J Infect Dis. 2021;108:270-3. doi: 10.1016/j.ijid.2021.05.056.

High-flow oxygen therapy in elderly patients infected with SARS-CoV2 with a contraindication for transfer to an intensive care unit: a preliminary report.
Lagier JC, Amrane S, Mailhe M, et al.
Int J Infect Dis. 2021;108:1-3. doi: 10.1016/j.ijid.2021.03.087.

Predictors of severe hypoxemia among COVID-19 patients in Burkina Faso (West Africa): findings from hospital based cross-sectional study.
Diendere EA, Sondo KA, Ouedraogo AR, et al.
Int J Infect Dis. 2021;108:289-95. doi: 10.1016/j.ijid.2021.04.007.

Day-by-day symptoms following positive and negative PCR tests for SARS-CoV-2 in non-hospitalized healthcare workers: a 90-day follow-up study.
Nielsen KJ, Vestergaard JM, Schlunssen V, et al.
Int J Infect Dis. 2021;108:382-90. doi: 10.1016/j.ijid.2021.05.032.

Clinical presentation, outcomes and factors associated with mortality: a prospective study from three COVID-19 referral care centres in West Africa.
Jaspard M, Sow MS, Juchet S, et al. for the COVISTA study group.
Int J Infect Dis. 2021;108:45-52. doi: 10.1016/j.ijid.2021.05.024.

Diagnostics
-----------
Evaluation of the AMP SARS-CoV-2 rapid antigen test in a hospital setting.
Leixner G, Voill-Glaninger A, Bonner E, et al.
Int J Infect Dis. 2021;108:353-6. doi: 10.1016/j.ijid.2021.05.063.

Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture.
Alshukairi AN, Tolah AM, Dada A, et al.
Int J Infect Dis. 2021;108:112-115. doi: 10.1016/j.ijid.2021.05.027.

Evaluation of sample treatments in a safe and straightforward procedure for the detection of SARS-CoV-2 in saliva.
Rubio CP, Franco-Martinez L, Resalt CS, et al.
Int J Infect Dis. 2021;108:413-8. doi: 10.1016/j.ijid.2021.05.053.

Comparative analysis of antigen and molecular tests for the detection of SARS-CoV-2 and related variants: A study on 4266 samples.
Caputo V, Bax C, Colantoni L, et al.
Int J Infect Dis. 2021;108:187-9. doi: 10.1016/j.ijid.2021.04.048.

Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy.
Lagi F, Trevisan S, Piccica M, et al.
Int J Infect Dis. 2021;108:231-6. doi: 10.1016/j.ijid.2021.04.065.

Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
Hirotsu Y, Sugiura H, Maejima M, et al.
Int J Infect Dis. 2021;108:263-269. doi: 10.1016/j.ijid.2021.05.067.

Modeling the early temporal dynamics of viral load in respiratory tract specimens of COVID-19 patients in Incheon, the Republic of Korea.
Lim AY, Cheong HK, Oh YJ, et al.
Int J Infect Dis. 2021;108:428-434. doi: 10.1016/j.ijid.2021.05.062.

Colloidal gold immunochromatographic assay (GICA) is an effective screening method for identifying detectable anti-SARS-CoV-2 neutralizing antibodies.
Li X, Yin Y, Pang L, et al.
Int J Infect Dis. 2021;108:483-6. doi: 10.1016/j.ijid.2021.05.080.

Parallel detection of SARS-CoV-2 RNA and nucleocapsid antigen in nasopharyngeal specimens from a COVID-19 patient screening cohort.
Mayanskiy N, Brzhozovskaya E, Fedorova N, et al.
Int J Infect Dis. 2021;108:330-2. doi: 10.1016/j.ijid.2021.05.082.

Treatment
---------
Candesartan as a tentative treatment for COVID-19: a prospective non-randomized open-label study.
Lukito AA, Widysanto A, Lemuel TAY, et al.
Int J Infect Dis. 2021;108:159-166. doi: 10.1016/j.ijid.2021.05.019.

Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: a cohort study.
Kamstrup P, Sivapalan P, Eklof J, et al.
Int J Infect Dis. 2021;108:370-376. doi: 10.1016/j.ijid.2021.05.076.

Effect of ammonium chloride in addition to standard of care in outpatients and hospitalized COVID-19 patients: a randomized clinical trial.
Siami Z, Aghajanian S, Mansouri S, et al.
Int J Infect Dis. 2021;108:306-8. doi: 10.1016/j.ijid.2021.04.043.

Efficacy and safety of nintedanib for pulmonary fibrosis in severe pneumonia induced by COVID-19: an interventional study.
Umemura Y, Mitsuyama Y, Minami K, et al.
Int J Infect Dis. 2021;108:454-60. doi: 10.1016/j.ijid.2021.05.055.

Pathophysiology
---------------
Non-ABO red cell antibodies and risk of COVID-19.
Ray JG, Colacci M, Schull MJ, et al.
Int J Infect Dis. 2021;108:179-82. doi: 10.1016/j.ijid.2021.05.038.

COVID-19: autopsy findings in six patients between 26 and 46 years of age.
Greuel S, Ihlow J, Dragomir MP, et al.
Int J Infect Dis. 2021;108:274-81. doi: 10.1016/j.ijid.2021.05.069.

Role of testosterone in SARS-CoV-2 infection: a key pathogenic factor and a biomarker for severe pneumonia.
Camici M, Zuppi P, Lorenzini P, et al and the ReCoVeRi Study Group.
Int J Infect Dis. 2021;108:244-51. doi: 10.1016/j.ijid.2021.05.042.

Post-mortem examination of hospital inpatient COVID-19 deaths in Lusaka, Zambia -- a descriptive whole-body autopsy series.
Himwaze CM, Telendiy V, Maate F, et al.
Int J Infect Dis. 2021;108:363-9. doi: 10.1016/j.ijid.2021.06.013.

Vaccines and vaccination
------------------------
Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals.
Sasikala M, Shashidhar J, Deepika G, et al.
Int J Infect Dis. 2021;108:183-6. doi: 10.1016/j.ijid.2021.05.034.

Epidemiology
------------
Tracking COVID-19 with wastewater to understand asymptomatic transmission.
Wannigama DL, Amarasiri M, Hurst C, et al.
Int J Infect Dis. 2021;108:296-299. doi: 10.1016/j.ijid.2021.05.005.

SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021.
Murhekar MV, Bhatnagar T, Thangaraj JWV, et al and the ICMR Serosurveillance Group.
Int J Infect Dis. 2021;108:145-155. doi: 10.1016/j.ijid.2021.05.040.

Clinical and epidemiological characteristics of children with COVID-19 in Negeri Sembilan, Malaysia.
Ng DC, Tan KK, Chin L, et al.
Int J Infect Dis. 2021;108:347-352. doi: 10.1016/j.ijid.2021.05.073.

Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil.
de Siqueira IC, Camelier AA, Maciel EAP, et al.
Int J Infect Dis. 2021;108:252-5. doi: 10.1016/j.ijid.2021.05.010.

Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: a case study.
Sevillano G, Ortega-Paredes D, Loaiza K, et al.
Int J Infect Dis. 2021;108:53-56. doi: 10.1016/j.ijid.2021.04.073.

Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: analysis of multiple factors.
Luo C, Liu M, Li Q, et al.
Int J Infect Dis. 2021;108:57-62. doi: 10.1016/j.ijid.2021.04.078.

SARS-CoV-2 reinfection with a virus harboring mutation in the spike and the nucleocapsid proteins in Panama.
Diaz Y, Ortiz A, Weeden A, et al and the Gorgas COVID19 Team.
Int J Infect Dis. 2021;108:588-91. doi: 10.1016/j.ijid.2021.06.004.

Association between traffic inflow and COVID-19 prevalence at the provincial level in South Korea.
Lee H, Noh E, Jeon H, et al.
Int J Infect Dis. 2021;108:435-442. doi: 10.1016/j.ijid.2021.05.054.

Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness.
Lednicky JA, Lauzardo M, Alam MM, et al.
Int J Infect Dis. 2021;108:212-6. doi: 10.1016/j.ijid.2021.04.063.

The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: results from a statewide sentinel-based population survey in Karnataka, India.
Babu GR, Sundaresan R, Athreya S, et al.
Int J Infect Dis. 2021;108:27-36. doi: 10.1016/j.ijid.2021.05.043.

Prevalence of COVID-19 in children, adolescents and adults in remote education situations in the city of Fortaleza, Brazil.
Pinto Jr VC, Moura LFWG, Cavalcante RC, et al.
Int J Infect Dis. 2021;108:20-6. doi: 10.1016/j.ijid.2021.04.086.

Public health
-------------
Underreporting of race/ethnicity in COVID-19 research.
Raghav K, Anand S, Gothwal A, et al.
Int J Infect Dis. 2021;108:419-21. doi: 10.1016/j.ijid.2021.05.075.

An analysis of COVID-19 vaccine sentiments and opinions on Twitter.
Yousefinaghani S, Dara R, Mubareka S, et al.
Int J Infect Dis. 2021;108:256-262. doi: 10.1016/j.ijid.2021.05.059.

The importance of timely contact tracing -- a simulation study.
Mettler SK, Park J, Ozbek O, et al.
Int J Infect Dis. 2021;108:309-319. doi: 10.1016/j.ijid.2021.04.029.

COVID-19 outbreaks at shelters for women who are victims of gender-based violence from Ecuador.
Vallejo-Janeta AP, Morales-Jadan D, Freire-Paspuel B, et al and the UDLA COVID-19 team.
Int J Infect Dis. 2021;108:531-6. doi: 10.1016/j.ijid.2021.06.012.

Vaccines
--------
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection.
Vicenti I, Gatti F, Scaggiante R, et al.
Int J Infect Dis. 2021;108:176-8. doi: 10.1016/j.ijid.2021.05.033.

The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout.
Zaqout A, Daghfal J, Alaqad I, et al.
Int J Infect Dis. 2021;108:116-8. doi: 10.1016/j.ijid.2021.05.021.

Case reports
------------
Transient perivascular inflammation of the carotid artery (TIPIC) syndrome in a patient with COVID-19.
Mumoli N, Evangelista I, Colombo A, et al.
Int J Infect Dis. 2021;108:126-8. doi: 10.1016/j.ijid.2021.05.017.

Non-COVID-19 collection
-----------------------
Bacterial infections
--------------------
Exploring clustering of leprosy in the Comoros and Madagascar: a geospatial analysis.
Ortuno-Gutierrez N, Mzembaba A, Ramboarina S, et al.
Int J Infect Dis. 2021;108:96-101. doi: 10.1016/j.ijid.2021.05.014.

Combination of aztreonam, ceftazidime-avibactam and amikacin in the treatment of VIM-1 _Pseudomonas aeruginosa_ ST235 osteomyelitis.
Mularoni A, Mezzatesta ML, Pilato M, et al.
Int J Infect Dis. 2021;108:510-2. doi: 10.1016/j.ijid.2021.05.085.

Clinical characteristics of pyogenic vertebral osteomyelitis, and factors associated with inadequate treatment response.
Geisler Crone C, Mose Tetens M, Bengaard Andersen A.
Int J Infect Dis. 2021;108:487-493. doi: 10.1016/j.ijid.2021.05.078.

Recent increased incidence of invasive serogroup W meningococcal disease: a retrospective observational study.
Hovmand N, Lundbo LF, Kronborg G, et al.
Int J Infect Dis. 2021;108:582-7. doi: 10.1016/j.ijid.2021.05.086.

Disease burden of bloodstream infections caused by antimicrobial-resistant bacteria: a population-level study, Japan, 2015-2018.
Tsuzuki S, Matsunaga N, Yahara K, et al.
Int J Infect Dis. 2021;108:119-24. doi: 10.1016/j.ijid.2021.05.018.

Deep surgical site infections following double-dose perioperative antibiotic prophylaxis in adult obese orthopedic patients.
Hasler A, Unterfrauner I, Olthof MGL, et al.
Int J Infect Dis. 2021;108:537-42. doi: 10.1016/j.ijid.2021.06.008.

Prospective surveillance for invasive _Staphylococcus aureus_ and group A _Streptococcus_ infections in a setting with high community burden of scabies and impetigo.
Thean LJ, Jenney A, Engelman D, et al.
Int J Infect Dis. 2021;108:333-9. doi: 10.1016/j.ijid.2021.05.041.

Comparison of piperacillin plasma concentrations in a prospective randomised trial of extended infusion versus intermittent bolus of piperacillin/tazobactam in paediatric patients.
Chongcharoenyanon T, Wacharachaisurapol N, Anugulruengkitt S, et al.
Int J Infect Dis. 2021;108:102-8. doi: 10.1016/j.ijid.2021.05.044.

Rapid identification of bacteria from respiratory samples of patients hospitalized in intensive care units, with FilmArray Pneumonia Panel Plus.
Camelena F, Poncin T, Dudoignon E, et al.
Int J Infect Dis. 2021;108:568-73. doi: 10.1016/j.ijid.2021.05.074.

Syphilis diagnosis and serological response to benzathine penicillin G among patients attending HIV clinics in N'Djamena, Chad.
Adawaye C, Souleymane AO, Fouda AA, et al.
Int J Infect Dis. 2021;108:461-464. doi: 10.1016/j.ijid.2021.05.051.

Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A retrospective cohort study.
Almangour TA, Alruwaili A, Almutairi R, et al.
Int J Infect Dis. 2021;108:406-12. doi: 10.1016/j.ijid.2021.06.007.

Incidence and microbiological characteristics of neonatal late onset sepsis in a neonatal intensive care unit in Peru.
Herbozo C, Julca I, Flores F, et al
Int J Infect Dis. 2021;108:171-5. doi: 10.1016/j.ijid.2021.05.012.

Plasma fibrinogen is a reliable marker for diagnosing periprosthetic joint infection and determining the timing of second-stage revision.
Xu H, Shang G, Wang Y, et al.
Int J Infect Dis. 2021;108:220-5. doi: 10.1016/j.ijid.2021.05.068.

Tuberculosis
------------
Rapid discrimination between tuberculosis and sarcoidosis using next-generation sequencing.
Chao Y, Li J, Gong Z, et al.
Int J Infect Dis. 2021;108:129-136. doi: 10.1016/j.ijid.2021.05.028.

Impact of the COVID-19 pandemic on tuberculosis management in Spain.
Aznar ML, Espinosa-Pereiro J, Saborit N, et al.
Int J Infect Dis. 2021;108:300-305. doi: 10.1016/j.ijid.2021.04.075.

Time-dependent association between cancer and risk of tuberculosis: a population-based cohort study.
Shen BJ, Lin HH.
Int J Infect Dis. 2021;108:340-346. doi: 10.1016/j.ijid.2021.05.037.

Diagnostic yield of Xpert MTB/RIF on contrast-enhanced ultrasound-guided pleural biopsy specimens for pleural tuberculosis.
Sun W, Zhou Y, Li W, et al.
Int J Infect Dis. 2021;108:89-95. doi: 10.1016/j.ijid.2021.05.023.

Situational analysis of 10 countries with a high burden of drug-resistant tuberculosis 2 years post-UNHLM declaration: progress and setbacks in a changing landscape.
Monedero-Recuero I, Gegia M, Wares DF, et al.
Int J Infect Dis. 2021;108:557-567. doi: 10.1016/j.ijid.2021.06.022.

Additional drug resistance for _Mycobacterium tuberculosis_ during turnaround time for drug-susceptibility testing in China: a multicenter observational cohort study.
Zhu J, Bao Z, Xie Y, et al.
Int J Infect Dis. 2021;108:81-8. doi: 10.1016/j.ijid.2021.04.027.

Integrating tuberculosis screening into antenatal visits to improve tuberculosis diagnosis and care: results from a pilot project in Pakistan.
Ali RF, Siddiqi DA, Malik AA, et al.
Int J Infect Dis. 2021;108:391-6. doi: 10.1016/j.ijid.2021.05.072.

Viral infections
----------------
Emergence of Indian lineage of ECSA chikungunya virus in Djibouti, 2019.
Fourie T, Dia A, Savreux Q, et al.
Int J Infect Dis. 2021;108:198-201. doi: 10.1016/j.ijid.2021.03.090.

Epidemiology of enteric virus infections in children living in the Amazon region.
Olivares AIO, Leitao GAA, Pimenta YC, et al.
Int J Infect Dis. 2021;108:494-502. doi: 10.1016/j.ijid.2021.05.060.

Changing influenza activity in the Southern hemisphere countries during the COVID-19 pandemic.
Kim J, Gomez Gomez RE, Hong K, et al.
Int J Infect Dis. 2021;108:109-111. doi: 10.1016/j.ijid.2021.05.039.

Point of care real-time polymerase chain reaction-based diagnostic for Kyasanur forest disease.
Majumdar T, Shete A, Yadav P, et al.
Int J Infect Dis. 2021;108:226-230. doi: 10.1016/j.ijid.2021.05.036.

SAA and CRP are potential indicators in distinction and severity assessment for children with influenza.
Zou S, Liu J, Yang Z, et al.
Int J Infect Dis. 2021;108:357-362. doi: 10.1016/j.ijid.2021.05.057.

Serum microRNAs predict response of patients with chronic hepatitis B to antiviral therapy.
Tan B, Liu M, Wang L, et al.
Int J Infect Dis. 2021;108:37-44. doi: 10.1016/j.ijid.2021.05.015.

A prospective, multicentre, cohort study to assess the incidence of dengue illness in households from selected communities in Brazil (2014-2018).
de Aguiar DF, de Barros ENC, Ribeiro GS, et al.
Int J Infect Dis. 2021;108:443-53. doi: 10.1016/j.ijid.2021.04.062.

HIV
---
Impact of the COVID-19 pandemic on HIV care in Guatemala.
Medina N, Alastruey-Izquierdo A, Bonilla O et al.
Int J Infect Dis. 2021;108:422-427. doi: 10.1016/j.ijid.2021.06.011.

Phylodynamic analysis reveals changing transmission dynamics of HIV-1 CRF01_AE in Japan from heterosexuals to men who have sex with men.
Otani M, Shiino T, Kondo M, et al for the Japanese Drug Resistance HIV-1 Surveillance Network.
Int J Infect Dis. 2021;108:397-405. doi: 10.1016/j.ijid.2021.05.066.

Parasitic infections
--------------------
Contrasting epidemiology and genetic variation of _Plasmodium vivax_ infecting Duffy-negative individuals across Africa.
Lo E, Russo G, Pestana K, et al.
Int J Infect Dis. 2021;108:63-71. doi: 10.1016/j.ijid.2021.05.009.

Comparative analysis of four malaria diagnostic tools and implications for malaria treatment in southwestern Nigeria.
Oboh MA, Oriero EC, Ndiaye T, et al.
Int J Infect Dis. 2021;108:377-81. doi: 10.1016/j.ijid.2021.05.049.

Failure of rapid diagnostic tests in _Plasmodium falciparum_ malaria cases among travelers to the UK and Ireland: identification and characterisation of the parasites.
Nolder D, Stewart L, Tucker J, et al.
Int J Infect Dis. 2021;108:137-44. doi: 10.1016/j.ijid.2021.05.008.

Molecular ecology of _Triatoma dimidiata_ in southern Belize reveals risk for human infection and the local differentiation of _Trypanosoma cruzi_ parasites.
Polonio R, Lopez-Dominguez J, Herrera C, et al.
Int J Infect Dis. 2021;108:320-9. doi: 10.1016/j.ijid.2021.05.083.

Evolving symptom networks in relation to HIV-positive duration among people living with HIV: A network analysis.
Zhu Z, Wen H, Yang Z, et al.
Int J Infect Dis. 2021;108:503-9. doi: 10.1016/j.ijid.2021.05.084.

Hospital infection control
--------------------------
Effects of a comprehensive antimicrobial stewardship program in a surgical intensive care unit.
Kim SH, Yoon JG, Park HJ, et al.
Int J Infect Dis. 2021;108:237-243. doi: 10.1016/j.ijid.2021.02.082.

The WHO methodology for point prevalence surveys on antibiotics use in hospitals should be improved: lessons from pilot studies in four Mexican hospitals.
Zumaya-Estrada FA, Alpuche-Aranda CM, Saturno-Hernandez PJ.
Int J Infect Dis. 2021;108:13-7. doi: 10.1016/j.ijid.2021.04.079.

Vaccines and vaccine preventable infections
-------------------------------------------
Maternal human papillomavirus infections at mid-pregnancy and delivery in a Scandinavian mother-child cohort study.
Vaernesbranden MR, Wiik J, Sjoborg K, et al.
Int J Infect Dis. 2021;108:574-81. doi: 10.1016/j.ijid.2021.05.064.

Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: a randomized controlled phase 2 trial.
Sirima SB, Ouedraogo A, Barry N, et al.
Int J Infect Dis. 2021;108:465-472. doi: 10.1016/j.ijid.2021.05.061.

Rotavirus gastroenteritis in children hospitalized in northeastern Poland in 2006-2020: severity, seasonal trends, and impact of immunization.
Toczylowski K, Jackowska K, Lewandowski D, et al.
Int J Infect Dis. 2021;108:550-6. doi: 10.1016/j.ijid.2021.05.070.

Seroprevalence of measles and rubella antibodies in vaccinated and unvaccinated infants in the Lao People's Democratic Republic.
Hefele L, Xaydalasouk K, Kleine D, et al.
Int J Infect Dis. 2021;108:524-30. doi: 10.1016/j.ijid.2021.06.016.

Public health
-------------
Determinants of trends in reported antibiotic use among sick children under five years of age across low-income and middle-income countries in 2005-17: a systematic analysis of user characteristics based on 132 national surveys from 73 countries.
Allwell-Brown G, Hussain-Alkhateeb L, Sewe MO, et al.
Int J Infect Dis. 2021;108:473-482. doi: 10.1016/j.ijid.2021.05.058.

Live poultry feeding and trading network and the transmission of avian influenza A(H5N6) virus in a large city in China, 2014-2015.
Zhang R, Lei Z, Liu C, et al.
Int J Infect Dis. 2021;108:72-80. doi: 10.1016/j.ijid.2021.05.022.

First report of epidemic dengue fever and malaria co-infections among internally displaced persons in humanitarian camps of North Darfur, Sudan.
Ahmed A, Eldigail M, Elduma A, et al.
Int J Infect Dis. 2021;108:513-6. doi: 10.1016/j.ijid.2021.05.052.

Weaponizing water as an instrument of war in Syria: Impact on diarrhoeal disease in Idlib and Aleppo governorates, 2011-2019.
Abbara A, Zakieh O, Rayes D, et al.
Int J Infect Dis. 2021;108:202-8. doi: 10.1016/j.ijid.2021.05.030.

Prevalence of cervical HPV infection, sexually transmitted infections and associated antimicrobial resistance in women attending cervical cancer screening in Mali.
Jary A, Teguete I, Sidibe Y, et al.
Int J Infect Dis. 2021;108:610-616. doi: 10.1016/j.ijid.2021.06.024.

Case reports
------------
Rhino-orbital entomophthoromycosis.
Liu Y, Zhang Y, Ye J, Yan D.
Int J Infect Dis. 2021;108:522-3. doi: 10.1016/j.ijid.2021.05.081.

Microsporidiosis in a solid organ transplant recipient.
Seneghini M, Petermichl V, Frei R, et al.
Int J Infect Dis. 2021;108:18-9. doi: 10.1016/j.ijid.2021.04.084.

'Starry sky' appearance on brain CT in neurocysticercal encephalitis.
Niang I, Ndiaye B, Diouf PMD, et al.
Int J Infect Dis. 2021;108:4-5. doi: 10.1016/j.ijid.2021.05.004.

Anthrax meningoencephalitis complicated with brain abscess -- a case report.
Popescu CP, Zaharia M, Nica M, et al.
Int J Infect Dis. 2021;108:217-219. doi: 10.1016/j.ijid.2021.05.013.

Two cases of hand, foot and mouth disease caused by enterovirus A71 after vaccination.
Tang J, Zhang Z, Zhang Z, et al.
Int J Infect Dis. 2021;108:190-197. doi: 10.1016/j.ijid.2021.03.039.

Corrigendum
-----------
Corrigendum to "_Helicobacter pylori_, clinical, laboratory, and noninvasive biomarkers suggestive of gastric damage in healthy school-aged children: A case-control study" [Int J Infect Dis. 2021; 103:423-430].
Lucero Y, Lagomarcino AJ, Torres JP, et al.
Int J Infect Dis. 2021;108:125. doi: 10.1016/j.ijid.2021.05.046.

--
communicated by:
ProMED
<promed@promedmail.org>

[The International Society for Infectious Diseases (ISID) is proud to announce a new journal, "IJID Regions", open for submission and registration from 1 Aug 2021 (https://www.editorialmanager.com/ijregi/default.aspx).

IJID Regions aims to
- publish high-quality, evidence-based infectious disease science of regional interest and relevance;
- enhance visibility of regional research with focus on those infectious diseases that are common in under-resourced countries and settings;
- publish research that can be utilized by national and regional health clinicians, scientists, health systems, and public health policy makers.

IJID Regions focuses on clinical infectious diseases, clinical epidemiology, and public health and publishes original clinical and laboratory-based research, together with reports of clinical trials and reviews dealing with the epidemiology, clinical diagnosis, treatment, and control of infectious diseases.

We encourage authors to collaborate between institutions to ensure good sample size and firm conclusions. Prospective, randomised controlled trials are preferred over retrospective, descriptive studies. - Mod.EP]
See Also
New in IJID (06): June 2021 20210722.8536790
New in IJID (05): May 2021 20210516.8364910
New in IJID (04): April 2021 120210421.8319851
New in IJID (03): March 2021 20210316.8250191
New in IJID (02): February 2021 20210210.8182520
New in IJID (01): January 2021 20210114.8102611
2020
---
New in IJID (12): December 2020 20201209.8005250
New in IJID (11): November 2020 20201117.7950604
New in IJID (10): October 2020 20201023.7884336
New in IJID (09): September 2020 20200906.7752141
New in IJID (08): August 2020 20200811.7665897
New in IJID (07): July 2020 20200715.7576950
.................................................ep/mj/sh
</body>
